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ABSTRACT: Members of the genus Clostridium represent a
diverse assemblage of species exhibiting both medical and
industrial importance. Deriving both a greater understanding
of their biology, while at the same time enhancing their
exploitable properties, requires eﬀective genome editing tools.
Here, we demonstrate the ﬁrst implementation in the genus of
theophylline-dependent, synthetic riboswitches exhibiting a
full set of dynamic ranges, also suitable for applications where
tight control of gene expression is required. Their utility was
highlighted by generating a novel riboswitch-based editing
toolRiboCasthat overcomes the main obstacles associ-
ated with CRISPR/Cas9 systems, including low transformation eﬃciencies and excessive Cas9 toxicity. The universal nature of
the tool was established by obtaining chromosomal modiﬁcations in C. pasteurianum, C. dif f icile, and C. sporogenes, as well as by
carrying out the ﬁrst reported example of CRISPR-targeted gene disruption in C. botulinum. The high eﬃciency (100% mutant
generation) and ease of application of RiboCas make it suitable for use in a diverse range of microorganisms.
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C lostridium is a large genus of Gram-positive, anaerobic,spore-forming bacteria that includes species relevant to
human and animal diseases as well as representatives with
application in biotechnological processes.1 Those members of
the genus that cause disease include the notorious pathogens
Clostridium botulinum,2 Clostridium perf ringens,3 and Clostri-
dium dif f icile.4 The majority of the genus are, however, entirely
benign and form the basis of commercial processes concerned
with the production of platform chemicals and biofuels (e.g.,
Clostridium pasteurianum,5,6 Clostridium acetobutylicum7);
cellulosic and hemicellulosic biomass degradation (e.g.,
Clostridium thermocellum8); carbon ﬁxation (e.g., Clostridium
ljungdahlii9 and Clostridium autoethanogenum10); and anti-
cancer therapeutics (e.g., Clostridium sporogenes11,12). Regard-
less of their extraordinary diversity, deriving both a greater
understanding of their biology, while at the same time
enhancing their exploitable properties, requires ever more
sophisticated approaches. This challenge is met by the
emerging ﬁeld of synthetic biology, which can provide
common tools for engineering new functionalities in pathogens
and industrial strains alike.
Adding to a growing list of available synthetic biology tools,
are those based on the Streptococcus pyogenes CRISPR/Cas9
system (clustered regularly interspaced short palindromic
repeats/CRISPR-associated proteins) which can form the
basis of rapid and reliable methods for genome editing. In
prokaryotes, genome editing is reliant on recombination-based
replacement of a parental sequence with the desired mutant
allele and subsequent elimination of the progenitor cell
population through RNA-guided, Cas9 cleavage of the parental
allele. It follows that in the ideal system, a tightly regulated
promoter should be used to initially prevent production of
Cas9 until the allelic exchange necessary to generate the
desired mutant cell population has taken place. Restricting the
time during which Cas9 is present also reduces the opportunity
for potential oﬀ target eﬀects and the likelihood of mutations
that inactivate Cas9 or the sgRNA. Those systems described in
Clostridium species to date have largely used constitutive
promoters to control Cas9 production or promoters that are
poorly repressed.13−18 In general, their eﬀectiveness has been
hindered by low transformation and/or editing eﬃciencies.
The use of a Cas9 nickase (nCas9), a Cas9 mutant that
introduces a breakage on only one strand of the chromo-
some,19 has been shown to enable the isolation of Clostridium
mutants.20,21 However, because nCas9 has a less powerful
selection capacity than Cas9, the isolation of mutants becomes
more time-consuming, requiring several passages onto fresh
medium.20
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To address these limitations, we sought to exploit the
versatility of bacterial riboswitches to engineer a ligand-
responsive system with the adequate ON/OFF states for
CRISPR-based applications. These natural genetic control
elements, located primarily within the 5′ untranslated region of
mRNA (5′ UTR), regulate gene expression in a ligand-
dependent manner and in the absence of protein factors.22
Riboswitches can also be engineered to respond to speciﬁc
ligands and are therefore of great beneﬁt for synthetic biology
applications. In particular, the well characterized synthetic
theophylline responsive riboswitch,23 has been shown to work
successfully in diverse bacterial species,24−29 suggesting its
potential transferability to other prokaryotes.
The strong repression and dynamic range of some of the
theophylline responsive riboswitches obtained in this study
allowed the development of a novel and highly eﬃcient
CRISPR system, named RiboCas, which regulates the
expression of Cas9 at the level of translation. We further
demonstrate the universality of RiboCas by obtaining
chromosomal modiﬁcations in the four diﬀerent clostridial
species C. sporogenes, C. pasteurianum, C. dif f icile, and
C. botulinum. We suggest that the high eﬃciency and easy
application of RiboCas make it a versatile genome editing tool,
applicable to diverse microorganisms and synthetic biology
endeavors.
■ RESULTS
Riboswitches Demonstrate Theophylline Depend-
ency in Clostridium. As previous work had shown that
many diverse theophylline-dependent riboswitches were func-
tional in both Gram-positive and Gram-negative bacteria,28 we
ﬁrst sought to evaluate the performance of this inducible
translational regulatory system in C. sporogenes NCIMB 10696.
We selected three riboswitch sequences, riboswitch-D, -E, and
-E*, which were expected to exhibit higher translation
eﬃciencies in the “on” state, out of the six theophylline-
responsive riboswitches developed by Gallivan and co-
workers.23,28 In previous publications, riboswitch-E* was
Figure 1. E. coli/Clostridium shuttle plasmid pMTL-IC101 and theophylline-riboswitch gene-control function. (a) E. coli/Clostridium shuttle
plasmid pMTL-IC101 containing the catP reporter gene under the control of Pfdx. Riboswitches-D to -J (Rb-D to -J) were placed downstream of
the TSS. (−) is the Gram-negative ColE1 RNA II origin of replication that allows replication of the shuttle plasmid in E. coli. (+) is the Gram-
positive replicon derived from the Clostridium botulinum plasmid pBP1. (b) Schematic representation of a functional model of the theophylline
responsive riboswitch. In the absence of theophylline, the riboswitch forms a stem-loop structure that sequesters the ribosome binding site (RBS)
in the mRNA transcript. When theophylline binds to the aptamer, the riboswitch conformation changes resulting in the release of the RBS and
initiation of translation of the gene of interest (catP).
Figure 2. Theophylline-riboswitch performance in Clostridium. (a) CAT activity and its ligand-dependent induction in each pMTL-IC111 reporter
plasmid. The reporter plasmids pMTL-IC101 (Pfdx-catP), pMTL-IC001 (promoterless catP), as well as the WT strain were used as controls. Error
bars represent standard deviations of three biological replicates. Asterisks indicate statistically signiﬁcant induction values for *p ≤ 0.0332, **p ≤
0.0021, ***p ≤ 0.0002, ****p ≤ 0.0001 (paired two-tailed Student’s t-test). (b) Activation ratio of riboswitches -D to -J. The activation ratio in
each riboswitch-based reporter plasmid was calculated by dividing the value of CAT activity measured in the presence of the inducer by the value of
that in the absence of inducer.
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shown to be the best theophylline-dependent riboregulator in
Gram-positive bacteria, thanks to its high dynamic range and
its very low basal expression.25−27,29 Accordingly, four new
riboswitches (named -F to -I) were constructed by rationally
modifying the space between the Shine−Dalgarno sequence
(SD) and the translational start site of the original riboswitch-
E* (Table S1). A reporter plasmid, pMTL-IC101, derived
from the vector pMTL82251,30 was used as a chassis for all of
the subsequently created plasmids (Figure 1a). This backbone
contains the native promoter of the C. sporogenes ferredoxin
gene (Pfdx, associated with the protein coding gene
Clspo_c0087) upstream of catP, which encodes the reporter
enzyme Chloramphenicol Acetyl Transferase (CAT, EC:
2.3.1.28) and serves as a reference to compare CAT expression
measurements. As a default, the riboswitches, preceded by a
linker sequence, were genetically fused to the core region (−35
and −10) of the strong Pfdx, just downstream of the
transcription start site (TSS) and excluding the native 5′
UTR sequence, as previously described25 (Figure S1). Plasmid
constructs, designated pMTL-IC111-D to -J, were conjugated
into C. sporogenes and cultures of the resultant transconjugants
cells exposed to 2 mM theophylline inducer when they had
reached early exponential growth phase (OD600 ≈ 0.5). CAT
activity was determined in cell lysates derived from stationary
phase cultures cultivated in the presence or absence of the
inducer. As a control, a promoter-less backbone, pMTL-IC001,
was assembled to detect background reporter gene expression.
A detailed list of plasmids used in this study is provided in
Table S5.
The synthetic theophylline responsive riboswitch is
composed of an aptamer and a synthetic SD (Figure 1b).
Theoretically, transcription of the riboswitch under the control
of Pfdx occurs in a constitutive manner during cell growth.
However, the synthetic SD sequence located downstream of
the aptamer is sequestered via pairing with the stem of the
riboswitch, resulting in translational block. The binding of
theophylline releases the SD by altering the downstream base
pairing. As a consequence, gene translation occurs when the
ribosome binds to the SD.23 As shown in Figure 2a, strains
harboring riboswitches -E, -E*, -F, -G, -H, and -I exhibited
statistically signiﬁcant induction in C. sporogenes after addition
of 2 mM theophylline to the culture. In particular, riboswitch-
G outperformed previous theophylline-dependent ribos-
witches, demonstrating higher levels of CAT activity, low
leakage expression and the strongest activation ratio (Figure
2b). In all cases, the incorporation of any riboswitch in the 5′
UTR led to a strong reduction in CAT activity; this agrees with
previously published studies, indicating that secondary
structures near the RBS play a major role in the translation
of the downstream mRNA.23,25,27 CAT activity of cells
harboring the control pMTL-IC001 was similar to that from
cultures lacking the reporter backbone (wildtype, WT),
indicating no detectable transcriptional read-through.
Riboswitches Can Be Adjusted to the Desired
Regulatory Window. Due to the importance of having
inducible systems where gene expression can be controlled
within a deﬁned regulatory window, we sought to compare the
expression pattern of riboswitches -E, -G, and -H when placed
downstream of the core region of a synthetically weakened Pfdx,
named Pfdx4. Pfdx4 was generated by replacing the core elements
−10 and −35 of Pfdx with the same regulatory elements of the
constitutive promoter from the C. acetobutylicum ATCC 824
ptb gene (Pptb, associated with the protein coding gene
Ca_3076) (Figure 3a). Also, to further examine the regulatory
response of the theophylline responsive riboregulators in
Clostridia, riboswitches -E, -G and -H were fused to the
promoters Pfdx and Pfdx4 retaining the bases downstream the
TSS but excluding their native SD sequences, as previously
described24 (Figure S1). These sequences, named Pfdx* and
Pfdx4*, maintain the full upstream region, including the core
region (−35 and −10), the TSS and the space between the
TSS and the native SD. Constructs were designed to express
the reporter gene catP, conjugated into C. sporogenes and
growing cultures of the transconjugants obtained exposed to 2
mM of theophylline inducer. As shown in Figure 3b, the
combination of diﬀerent riboswitches with various promoters
and two diﬀerent 5′ UTRs allows the expansion of the
regulatory range, providing a library of theophylline-inducible
Figure 3. Tuned response of theophylline-riboswitches. (a) The sequences of the constructed theophylline-responsive switches. The predicted −35
and −10 sequences are in bold. The experimentally determined TSS via 5′ RACE (Figure S2) are indicated with +1. The 5′ UTR sequences
downstream of the TSS are underlined. Core elements replaced to create the synthetic hybrid promoter Pfdx4 are in red. (b) Library of theophylline-
dependent riboswitches tested in C. sporogenes in the presence and absence of the inducer. The reporter plasmids pMTL-IC201 (Pfdx4-catP),
pMTL-IC101 (Pfdx-catP), and pMTL-IC001 (promoterless catP) were used as controls. Error bars represent standard deviations of three biological
replicates. Asterisks indicate statistically signiﬁcant induction values (paired two-tailed Student’s t-test).
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switches suitable for applications where protein yield is crucial
as well as for the expression of detrimental or toxic proteins.
The combination of any riboswitch with the weak promoter
Pfdx4 led to the lowest expression levels. This was also the case
when the native 5′ UTR sequence was retained, establishing a
direct correlation between detected CAT activity and
promoter strength (Pfdx > Pfdx4). However, basal expression
appears to be compromised when high expression levels are
achieved, resulting in increased leakiness in those constructs
that exhibited higher expression levels (i.e., with Pfdx*-G).
Expression of catP was always higher when the native sequence
downstream of the TSS was maintained.
Gene Expression and Transcript Abundance. Although
the primary aim of this study was to determine whether the
theophylline responsive riboswitch works in Clostridia, we also
attempted to further characterize certain aspects of ribor-
egulator function. It is well-known that the RNA structure
plays an important role in controlling both mRNA tran-
scription31 and protein synthesis.32,33 It follows that the
response of the theophylline responsive riboswitch can be
altered, or even abolished, by modifying the 5′ UTR.27 This
also implies that the performance of a given riboswitch will
inevitably be dependent on the genetic context. Therefore, we
sought to determine whether the diﬀerences in inducible CAT
expression observed when using diﬀerent 5′ UTRs were solely
due to the abundance of mRNA transcripts. To this end,
mRNA transcribed under the control of riboswitch-G located
downstream of either Pfdx or Pfdx* (Pfdx along with the native 5′
UTR sequence) was quantiﬁed via RT-qPCR.
Results showed a 2.5-fold increase in the mRNA transcribed
from Pfdx* compared with the mRNA transcribed from Pfdx, in
cultures induced with 2 mM theophylline (Figure 4). It should
be noted that this increase in mRNA levels was accompanied
by a 2.6-fold increase in CAT expression (Figure 3b), as
summarized in Table S6, which suggests a direct link between
the relative abundance of catP transcripts and CAT expression.
The levels of mRNA when Pfdx is placed upstream of the
riboswitch without its native 5′ UTR were similar in the
absence or presence of the inducer. Interestingly, there was a
signiﬁcant diﬀerence in the amount of transcript between the
on/oﬀ state in the case of Pfdx*, abundance being higher when
the inducer was added. These diﬀerences reﬂect the role the
sequence downstream of the TSS plays in mRNA abundance,
possibly as a result of a complex interplay between the
processes of transcription, translation and mRNA degradation.
Plausible explanations could include that the additional
nucleotides downstream of the TSS create an RNA
conformation that is less susceptible to degradation or that
the amount of transcript is indirectly inﬂuenced by the
conformation of the mRNA (i.e., with or without theophylline)
and its associated translation eﬃciency.32
Altogether, these data indicate that the studied riboswitch
responds to theophylline regardless of the genetic context and
that the appropriate combination of a riboswitch with a certain
promoter and the characterized 5′ UTRs would, therefore,
allow for the adjustment of a desired regulatory window.
Functional Characterization of Theophylline-Ribos-
witches in Clostridium. To assess the dose dependency of
riboswitch regulation, strains harboring plasmids that carried
the riboswitch-G downstream of Pfdx or Pfdx* were cultivated
with increasing concentrations of theophylline, ranging from
0.1 to 10 mM (Figure 5a). Increasing doses of theophylline
would be expected to result in higher levels of gene expression.
Concentrations higher than 5 mM, however, resulted in a
reduction of growth, in agreement with previously reported
results in other Gram-positive and Gram-negative bacteria34
(Figure 5b). The translational switches were also analyzed for
CAT expression over time in the presence and absence of 2
mM theophylline. As shown in Figure 5c, CAT expression
above the level of the uninduced culture was already detectable
30 min after induction (4.5 h of growth). The maximum level
of reporter gene expression was reached at 8 and 10 h when
using Pfdx and Pfdx*, respectively. Although both have a similar
proﬁle of induction, after 24 h, CAT expression was reduced
by 75% in Pfdx, whereas only by 40% in Pfdx*. Given that in
both cases the translated product is the same (CAT), these
results suggest that the reversal of induction is strongly
dependent on the abundance or stability of the mRNA.
The most eﬀective inducers are nonmetabolizable. To
establish whether this was the case in C. sporogenes, cells
were cultivated in TYG medium supplemented with 2 mM
theophylline. The concentration of theophylline was moni-
tored by HPLC−MS analysis of cell-free supernatant samples
over time. Results showed that the concentration of theophyl-
line remained constant over the course of the experiment, with
a slight and nonsigniﬁcant increase in the culture supernatant
20 h after induction. As a result of the manual processing of
several samples and the inevitable delay between culture
induction and sample harvesting, it is plausible that a small
quantity of theophylline could have already been uptaken by
the cells at T0. Some of this intracellular theophylline may
have been released in the medium following cell lysis at 20 h,
thus accounting for the small increase of extracellular inducer
concentration observed at this time point (Figure 5d).
RiboCas: A Highly Eﬃcient CRISPR/Cas9-Based Tool
for Clostridium. With a tightly inducible gene expression
system for Clostridium to hand, we explored the possibility of
generating an eﬃcient clostridial genome editing tool based on
CRISPR/Cas9. Figure 6 illustrates the general RiboCas-based
editing process and the assembly of the RiboCas vector series,
generically named pRXCasN vectors, where X and N refer to
the riboswitch and the promoter driving the sgRNA,
respectively.
It contains the four unique restriction sites AscI, FseI, PmeI,
and SbfI, which are used for modular assembly. (−) is the
Gram-negative origin of replication that allows replication of
Figure 4. Pfdx-G and Pfdx*-G transcript abundance comparison.
Transcript abundance determined by RT-qPCR relative to two
reference genes, 16Srrn and gyrA. Total RNA was isolated from late
exponential cultures grown in the presence and absence of 2 mM
theophylline. Error bars represent standard deviations of three
biological replicates. Asterisks indicate statistically signiﬁcant
induction values (paired/unpaired two-tailed Student’s t-test).
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the shuttle plasmid in E. coli. (+) is the Gram-positive replicon.
The application-speciﬁc module harbors the components of
the editing tool, including the gene encoding Cas9, the sgRNA
and the homologous DNA template needed for homologous
recombination. The terminators CD0164 (derived from
C. dif f icile) and Tfdx (derived from the C. pasteurianum
ferredoxin gene) are placed downstream of cas9 and the
sgRNA, respectively. The system was designed to be
Figure 5. Characterization of theophylline riboswitches in C. sporogenes. Dynamic and kinetic proﬁles of the theophylline responsive riboswitch
located downstream of Pfdx or Pfdx*. (a) Response to diﬀerent concentrations of the inducer theophylline. Cells containing the reporter plasmid
with riboswitch-G downstream of either Pfdx or Pfdx* were cultivated in TYG medium supplemented with various concentrations of theophylline (0,
0.1, 0.5, 2, 5, and 10 mM) at early exponential growth phase (4 h of growth, OD600 ≈ 0.5); CAT activity was measured on cell lysates from
stationary cultures. (b) Optical density (OD600) of C. sporogenes harboring the same reporter plasmids in response to 0.1−10 mM of theophylline
supplemented at time zero. (c) CAT expression proﬁles over time. Cells harboring the reporter plasmids were cultivated in TYG media in the
absence or presence of 2 mM theophylline; CAT was measured on cell lysates from stationary cultures. (d) Stability proﬁle of theophylline in
C. sporogenes. In all cases, error bars represent the standard deviations of three biological replicates.
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compatible with our previous pMTL80000 vector series
enabling rapid exchange of selection markers and origins of
replication.30
In order to have an appropriate control over cas9 expression,
both in the uninduced state and after induction, we selected
two riboswitches, riboswitches -E and -G, from our riboswitch
library, both located downstream of the promoter Pfdx (Figure
2a). Riboswitch-E had shown the tightest repression in the
noninduced state among all tested riboswitches; on the other
hand, riboswitch-G showed higher background levels but
increased expression when the inducer was added. Two
promoters, the constitutive promoter of the Clostridium
acetobutylicum araE gene (ParaE, associated with the protein
coding gene Ca_1339) and the synthetic promoter J23119,
were chosen to bring about the expression of the sgRNA. Both
had been previously used for CRISPR strategies with
Clostridium species.21,35 In all cases, the editing template
comprised two homology arms composed of the regions of the
chromosome needed to replace the target region. As a proof-
of-principle, we decided to target the spoIIR gene
(Clspo_c01510, encoding the stage II sporulation protein R).
The DNA modules encoding either riboswitch-E or -G, cas9,
the sgRNA downstream of either ParaE or J23113 and the DNA
editing template were inserted into the pCB102-based modular
vector pMTL83151,30 yielding the following pRXCasN vector
series: pRECas1-IIR, pRECas2-IIR, pRGCas1-IIR, and
pRGCas2-IIR (Table S5). The same vectors lacking the
editing homology arms were assembled to determine the
killing capacity of Cas9, named pRECas1G-IIR, pRECas2G-
IIR, pRGCas1G-IIR, and pRGCas2G-IIR. Two vectors,
pRECasC and pRGCasC, lacking both the homology arms
and sgRNA, were also created as a control for conjugation
eﬃciency comparisons.
Transfer of the resulting vectors into C. sporogenes was
performed via conjugative plasmid transfer from an E. coli
donor, plating the conjugated cultures onto media supple-
mented with thiamphenicol in the presence and absence of 5
mM theophylline. As expected, the diﬀerent plasmid constructs
were transferred with diﬀerent conjugation eﬃciencies (Figure
7a). The combination of riboswitch-E and the promoter ParaE
upstream of the sgRNA (pRECas1) provided the highest
conjugation eﬃciency (1.21 × 10−7 CFU/donor; CFU: colony
forming units), comparable to the 1.46 × 10−7 CFU/donor
obtained with pRECasC (nontargeting Cas9). Conjugative
transfer of the control plasmids, pRECasC and pRGCasC,
resulted in similar colony counts on plates with and without
theophylline (Figure 7b), indicating a very low oﬀ-target
activity in the absence of the targeting module. In all cases the
conjugation eﬃciency was lower if riboswitch-G regulated the
expression of Cas9, which implies a higher background
expression level in the absence of the inducer and agrees
with our previous CAT results. No colonies were observed on
Figure 6. pRXCas vector series and RiboCas functionality. (a) Illustration of the RiboCas-mediated genome editing. Transformed cells survive on
selective media in the absence of theophylline due to the tight repression exerted by the riboswitch, which impedes the translation of the nuclease
Cas9. After induction, the translated Cas9 forms a complex with the sgRNA (Cas9-sgRNA) inducing a double-strand breakage on the target DNA.
(i) The Cas9-sgRNA complex is lethal to the unedited cells, which are killed during the process. (ii) Cells are able to survive only if homologous
recombination occurs between the gene-targeting plasmid and the genome. (b) Schematic illustration of the RiboCas vector.
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plates supplemented with theophylline if the sgRNA was
expressed, whether or not the editing template was included,
indicating highly eﬃcient Cas9-mediating killing of host cells
(Figure 7c). These results also suggest that it could be possible
to select mutant cells just after transformation if the
homologous recombination event had occurred during the
recovery time.
Individual colonies harboring the diﬀerent CRISPR/Cas9
vectors and the DNA editing template were picked and
transferred to selective plates in the presence of theophylline.
In all cases, amplicons of ∼2.2 kbp instead of ∼2.9 kbp size
were detected after screening, implying the expected ∼0.7 kbp
deletion of spoIIR and an editing eﬃciency of 100% (Figure
7d). Desired deletions were conﬁrmed by sequencing the PCR
products. Screening of uninduced colonies generated the
Figure 7. RiboCas eﬃciency. (a) Conjugation eﬃciency of diﬀerent RiboCas plasmids involved in CRISPR-mediated gene editing. Error bars
represent standard deviations of three biological replicates on three independent experiments. The data summarize the obtained editing results
from each RiboCas plasmid. (b) CFU obtained from conjugation of pRECas1C (RiboCas vector lacking both homology arms and sgRNA) on
selective media in the presence and absence of the inducer theophylline. (c) CFU obtained from conjugation of pRECas1G-IIR (RiboCas vector
lacking the homology arms) on selective media in the presence and absence of theophylline. (d) Conﬁrmation of the gene deletion using colony
PCR. Lane L, the 2-log DNA marker with sizes (kbp) on the left; lanes 1−8, colony PCR on colonies from selective plates containing theophylline;
lanes 9−16, colony PCR on colonies from selective plates lacking theophylline; WT (wildtype).
Figure 8. Deletion and insertion of DNA into the chromosome of C. sporogenes using RiboCas. (a) Schematic representation of the deletion of
spoIIE (via pRECas1-IIE) and the integration of an ARC in the spoIIE locus (via pRECas1-IIEin) in the chromosome of C. sporogenes. The ARC
comprises the ermB gene that confers resistance to the antibiotic erythromycin and the sequence encoding the reporter enzyme β-glucuronidase
from E. coli. (b) PCR screening of the spoIIE deletion and integration of the ARC. The 1.9, 7.2, and 4.3 kbp bands represent the spoIIE deletion,
ARC integration and WT genotypes, respectively. Lane L, 2-log DNA marker with sizes (kbp) on the left; lanes 1−8 uninduced colonies; lanes 9−
16 induced colonies.
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amplicon of the WT strain (2.9 kbp); sequencing of these PCR
products did not show insertions/deletions. These results
suggest that the dynamic range of riboswitch-E is appropriate
for a Cas9-base editing system, providing both undetectable
oﬀ-target activity and high selection capacity. The consistency
of these results was conﬁrmed by three independent
experiments, verifying the robustness of the RiboCas system
and its suitability for more ambitious genome editing
strategies.
Application of RiboCas for the Deletion and
Integration of Larger Fragments. To further illustrate
the versatility of the RiboCas system we attempted to both
delete and integrate larger fragments into the genome of
C. sporogenes. The 2.4 kbp spoIIE gene (Clspo_c37040) was
selected as the target locus. Two sets of homology arms were
designed to either delete the target sequence or to integrate a 3
kbp cassette that encompasses a gene (ermB) that confers
resistance to erythromycin and the gene encoding the reporter
β-glucuronidase (gusA) from E. coli, together forming a large,
innocuous DNA cargo (Figure 8a). The editing templates and
the sgRNA sequences targeting spoIIE were cloned into
pRECas1 (the most eﬃcient RiboCas system in C. sporogenes
in terms of conjugation eﬃciency) generating pRECas1-IIE
(deletion vector) and pRECas1_IIEin (integration vector).
Both vectors were successfully conjugated into C. sporogenes.
After conjugation, induction of cas9 expression was performed
by restreaking individual colonies harboring pRECas1-IIE or
pRECas1-IIEin onto plates supplemented with thiamphenicol
and 5 mM theophylline. PCR was performed on uninduced
cultures and on colonies that had grown for 24 h in the
presence of the inducer. All of the screened colonies were
conﬁrmed as positive mutants for spoIIE deletion and
integration of the antibiotic resistance cassette (ARC) (Figure
8b). Generally, PCR products obtained from colonies grown in
the absence of the inducer corresponded to unedited cells,
demonstrating the tightness of RiboCas system in the absence
of the inducer. Only a few colonies (<10%) were composed of
mixtures of mutant and WT cells. Finally, to validate the
eﬃciency and detect oﬀ-target events that could have arisen
during the editing process, the genome of six independent
mutants of C. sporogenes was sequenced. In all of them, no
modiﬁcations apart from the intended editions were detected
when compared to the resequenced C. sporogenes parent strain.
RiboCas Demonstrates Universality in Clostridium. To
determine the applicability of the theophylline responsive
riboswitches and the RiboCas editing tool in other clostridial
species we ﬁrst sought to delete the same gene, spoIIE, in the
solventogenic species C. pasteurianum and in the pathogens
C. dif f icile and C. botulinum. Vectors pRECas1, containing the
homology arms and the sgRNA to target the spoIIE gene in
each species were introduced into the host organisms
C. pasteurianum DSM 525-H16, C. dif f icile 630 and the
group I C. botulinum strain ATCC 3502. C. pasteurianum was
transformed via electroporation, whereas plasmids were
introduced into C. dif f icile and C. botulinum by conjugative
plasmid transfer from an E. coli donor. Simultaneously, the
control plasmid pRECas1C (RiboCas vector lacking both
homology arms and sgRNA), was also introduced into the
diﬀerent hosts to determine the leakiness of the system and its
impact on the transformation/conjugation process. All trans-
formations were plated on media supplemented with
thiamphenicol, both in the presence and absence of theophyl-
line. The transformation frequency of the targeting RiboCas
vector in C. pasteurianum was only 20% lower than that of the
control vector (5000 CFU/μg DNA in pRECas1 vs 6500
CFU/μg DNA in pRECas1C) (Figure 9). On average a
transformation eﬃciency of 75 CFU/μg DNA was obtained on
plates containing theophylline, demonstrating that the
theophylline responsive riboregulator is functional in C. pas-
teurianum. PCR screening of these colonies conﬁrmed the
mutant genotype of the edited cells without the need of further
restreaking; the unedited phenotype was maintained on plates
lacking the inducer. Colonies from noninduced plates were
streaked onto plates containing both thiamphenicol and
theophylline and colony PCR used to conﬁrm their identity
as deletion mutants in 24 out of the 24 colonies screened
(100% eﬃciency) (Table 1). A similar transformation pattern
was found when conjugating the RiboCas vectors into
C. dif f icile and C. botulinum (data not shown), validating the
induction ability of riboswitches and the eﬃciency of the
RiboCas tool in both organisms. Screening of C. dif f icile
colonies after induction conﬁrmed an eﬃciency of 100% while
maintaining the WT phenotype on colonies not exposed to
theophylline (Table 1). Interestingly, and in contrast to the
results observed in other clostridial species, C. botulinum
colonies on plates lacking theophylline were composed of
either mutants or a mixture of mutant and WT populations.
This may suggest that although inducible, riboswitches exhibit
a higher background expression in C. botulinum but that the
selective capacity of Cas9 still allows the selection of only
edited cells.
A summary of the editing attempts carried out in this study,
including the protospacer sequence used, are summarized in
Table 1. It is worth noting that, despite pRECas1 being the
most eﬃcient in this study (in terms of conjugation eﬃciency),
vectors incorporating the promoter J23119 might be suitable
for organisms where ParaE is expected to be natively repressed
(i.e., in C. acetobutylicum).
■ DISCUSSION
This study shows the ﬁrst implementation of synthetic
riboswitches in the genus Clostridium and demonstrates their
application in highly eﬃcient genome editing. Previously
existing as well as newly designed theophylline-dependent
riboswitches were functional in C. sporogenes, with a response
Figure 9. Transformation eﬃciency of RiboCas into C. pasteurianum.
Transformation eﬃciencies of RiboCas plasmids in C. pasteurianum,
without (pRECasC) or with (pRECas-IIE) the spoIIE-targeting
sgRNA and the DNA editing template, when plated on selective
media in the absence and presence of the inducer theophylline.
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that is dependent on inducer concentration. In particular, the
novel riboswitch-G outperformed previously published ribos-
witches, exhibiting a large dynamic range and very low basal
expression. By replacing the promoter and modifying the 5′
UTR sequence located upstream of the riboswitch, we
generated a library of inducible switches with a full set of
dynamic ranges, suitable for applications where high levels of
gene expression are needed as well as for the expression of
detrimental proteins. In all cases, the riboswitch was able to
respond to the inducer theophylline, ensuring its performance
independent of the genetic context.
The usefulness of these tight and versatile riboregulators was
demonstrated by generating a novel riboswitch-based CRISPR
editing toolRiboCasthat overcomes the main obstacles
associated with Cas9 editing tools, including the very low
transformation eﬃciencies and the inability to select only
edited cells as a result of excessive Cas9 toxicity.36,37 We
attribute the high eﬃciency of RiboCas to several reasons.
First, the theophylline responsive riboswitch can be designed
to have the desired regulatory window, whereby there should
be very low basal expression of Cas9 in the absence of inducer,
allowing homologous recombination to occur before Cas9
mediates the site-speciﬁc double strand break, and after
induction, to be expressed at a level that is suﬃcient for
eﬀective genome DNA cleavage but which minimizes toxicity
that can be associated with Cas9 overexpression. Second,
riboswitches are smaller structures compared to systems that
require a transcription factor; in a riboswitch-based system, 84
nucleotides are enough to tightly control the expression of
Cas9, minimizing the size of the plasmid employed and
enabling higher transformation eﬃciencies. Third, because
repression occurs at the level of translation, the RiboCas
system allows the use of high-copy origins of replication,
avoiding the undesired eﬀects linked to read-through tran-
scription on the plasmid backbone and facilitating the
processes of cloning, screening, and sequencing. Finally, and
due to the aforementioned characteristics, RiboCas permits the
conﬁnement of all the essential components of a functional
genome editing tool to the same plasmid.
The universal nature of RiboCas was demonstrated through
its successful application in several clostridial species, including
the nonpathogen C. sporogenes, the solventogenic C. pasteur-
ianum, and the pathogens C. dif f icile and C. botulinum. The
derivation and application in C. sporogenes of a CRISPR-Cas9-
based system was recently reported.38 In contrast to our work,
mutants could be only obtained when the components of the
system were split between two separate vectors, one containing
the sgRNA and editing template and the other carrying cas9.
One consequence was that the conjugative transfer of the
second vector was only possible after 72 h of donor/acceptor
cocultivation; generally, the time required to transfer the
multicomponent RiboCas vector into C. sporogenes is 8 h.
Previous work had also enabled the use of Cas9 for editing
purposes in C. pasteurianum;13,14 however, the strategies
employed suﬀered from very low transformation eﬃciencies
that might compromise more ambitious applications. This is
also the case in C. dif f icile,17,18 where the performance of
CRISPR has been suboptimal. In particular, conjugation of
CRISPR plasmids in this organism has yielded invariably low
eﬃciencies. This is likely due to the high toxicity associated
with the Cas9 endonuclease activity. The recent application of
a CRISPR-Cpf1 editing tool enabled the deletion of various
genes with high eﬃciency.39 However, because Cpf1 nuclease
recognizes a T-rich PAM sequence (5′-TTTN-3′), we
hypothesize that oﬀ-target events across T-rich genomes
(such as those from species belonging to the genus
Clostridium) are more likely to occur if compared with Cas9,
which recognizes the PAM sequence 5′-GGN-3′.40 To our
knowledge, this is the ﬁrst report of CRISPR targeted gene
disruption in a C. botulinum chromosome.
As the ﬁeld of synthetic biology progresses toward more
practical applications, the technologies that have been
developed and optimized for model prokaryotes need to be
extended to more exotic chassis. This study provides a new set
of tools that facilitate the eﬃcient manipulation of clostridial
pathogens as well as those Clostridium species of industrial and
therapeutic relevance. As riboswitches are RNA-based devices
that control gene expression without the need of protein
factors, we anticipate that RiboCas will function in bacterial
chassis other than Clostridium and in a wide range of
applications for which tight control of gene expression is
required.
■ MATERIALS AND METHODS
Strains, Media, and Growth Conditions. All the E. coli
and Clostridium strains used in this study are listed in Table S2.
E. coli TOP10 (Invitrogen) was used as a general host for
plasmid construction and propagation. E. coli CA434 was used
as the donor strain for conjugation. Plasmid DNA for the
transformation of C. pasteurianum was methylated in vivo by
propagation in the E. coli host CR1, which harbors the plasmid
pCR1, encoding the M.BepI methyltransferase, as previously
described.6 All E. coli strains were transformed through
electroporation using a MicroPulser system (BioRad). E. coli
strains were grown at 30 or 37 °C, in Luria−Bertani (LB)
medium supplemented with chloramphenicol (25 μg/mL in
solid and 12.5 μg/mL in liquid media), erythromycin (500 μg/
mL) or kanamycin (50 μg/mL) when necessary. Growth
media for the diﬀerent Clostridium species are speciﬁed on
Table S3. Media for clostridial strains were supplemented with
the following antibiotic/inducer/supplement when appropri-
ate: thiamphenicol (15 μg/mL), erythromycin (10 μg/mL),
cefotoxin (16 μg/mL), D-cycloserine (500 μg/mL), theophyl-
line (0.1−10 mM), glucose 0.05% w/v. Clostridium strains
were grown at 37 °C in an anaerobic cabinet (MG1000
anaerobic workstation; Don Whitley Scientiﬁc Ltd.).
Reagents. All PCR reactions were performed using KOD-
Hot Start Polymerase 2X Master Mix (Merck Millipore) or
Table 1. Genome Editing Results in Diﬀerent Clostridium Species
strain target deletion (kpb) protospacer sequence eﬃciencya
C. pasteurianum DSM 525 spoIIE 2.4 ggaaactcctaaatatcacg 100
C. dif f icile 630 spoIIE 2.4 ggaattttagatttaaaacg 100
C. botulinum ATCC 3502 spoIIE 2.4 ttttataaagcgaggaactg 100
C. sporogenes NCBI 10696 spoIIE 2.4 ttaattataggatatgtaaa 100
a(Number of correctly edited transformants/total number of transformants screened) × 100.
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DreamTaq Green PCR Master Mix (Thermo Fisher
Scientiﬁc). T4 ligase (Promega) was used for DNA ligation
reactions. Restriction enzymes were purchased from New
England Biolabs. Theophylline was purchased from Sigma-
Aldrich.
Plasmid Design, Construction, and Transformation.
Oligonucleotide primers were synthesized by Sigma-Aldrich
and are listed in Table S4. Plasmids were constructed by
restriction enzyme-based cloning procedures.41 Constructs
were veriﬁed by DNA sequencing (Euroﬁns). All the plasmids
used in this study are listed in Table S5. Details of plasmid
construction are given in the Supporting Information.
Protospacer sequences were designed according to the
protocol described at http://benchling.com/pub/ellis-crspr-
tools.
Growth and CAT Activity Assays. For each tested
system, three independently conjugated C. sporogenes cultures
were grown for 12 h with selection before being diluted to a
starting OD600 of 0.01 in fresh medium. For evaluation of CAT
activity at a single time point, cultures were induced at an
OD600 ≈ 0.5 with 2 mM theophylline; cultures were collected
at stationary phase 4 h after induction. For CAT expression
assays over time, cultures were prepared as for the single time
point measurements, collecting the samples at the speciﬁc data
points. For dose-dependency assays, cultures were induced
with increasing concentrations of theophylline (0−10 mM). In
all cases, after sample collection, pellets were obtained and
stored at −20 °C until CAT activity was determined.
CAT activity was measured on cell lysates according to the
method of Shaw.42 Cell lysates were obtained using BugBuster
Master Mix lysis buﬀer (Novagen), according to the
manufacturer’s protocol. A 150 μL aliquot of a master mix,
consisting of 94 mM Tris buﬀer (pH 7.8), 0.19 mM acetyl
Coenzyme A, 0.0833 mM DTNB (5,5′-dithiobis-2-nitro-
benzoic acid), and 0.005% (w/v) chloramphenicol, was
injected into each well of a 96-well clear-bottom plate (Greiner
Bio One International) containing 10 μL of cell lysates and 40
μL of 100 mM Tris buﬀer (pH 7.8). Absorbance was measured
at 412 nm for 1 min using a CLARIOstar plate reader (MBG
Labtech GmbH), set at 25 °C. The rate of increase of
absorption was used to calculate CAT activity (U/mL) using
the following equation, where 0.2 is the total volume (in mL)
of assay, df is the dilution factor, 0.0136 is the micromolar
extinction coeﬃcient for DTNB at 412 nm,43 and 0.01 is the
volume of cell lysate used.
= Δ − ΔA test A blank df
Units/mL CAT
( /min /min )(0.2)( ))
(0.0136)(0.01)
412 412
CAT activity was further normalized by the total protein
concentrations obtained using a BCA assay (Thermo
Scientiﬁc).
For growth experiments, precultures grown for 12 h were
diluted to a starting OD600 of 0.01 with fresh medium
containing diﬀerent concentrations of the inducer theophylline
(0−10 mM). Because theophylline is dissolved in DMSO,
appropriate quantities of DMSO were added to all the cultures
to account for any eﬀect DMSO might have on growth.
HPLC−MS Analysis. To analyze if C. sporogenes consumes
theophylline, 12 h cultures were diluted to a staring OD600 of
0.01. At an OD600 of ≈0.5 cultures were induced with 2 mM
theophylline. Sample volumes of 1 mL samples were taken
immediately and then at 2, 4, 6, 8, 10, and 20 h after
supplementation of theophylline. Samples were centrifuged for
10 min and 10 000g. Supernatants were used to determine the
concentration of theophylline using an Alliance HT 2795
HPLC (Waters corporation) coupled to a Micromass Quattro
LC Mass Spectrometer (Waters Wilmslow) in positive mode
from m/z 70 to 500 for all samples at a scan rate of 1 cycle/s
and equipped with an electrospray source. The general
parameters were as follows: capillary voltage 2000 V, sampling
cone 30 V, source temperature 130 °C, desolvation temper-
ature 350 °C, cone gas ﬂow 64 L/h, and desolvation gas ﬂow
621 L/h.
Prior to ionization, chromatographic separation was
achieved using a Supelco Ascentis Express HPLC column
(100 mm × 3 mm, 2.7 μM, Sigma-Aldrich). The mobile phase
consisted of (A) water with 0.1% v/v formic acid and (B)
methanol with 0.1% v/v formic acid. In all HPLC runs the
elution gradient started at 95% A, 5% B increasing to 10% A,
90% B, followed by a 5 min re-equilibration period. A sample
volume of 10 μL was injected for each HPLC run. The column
was operated at 40 °C with a ﬂow rate of 0.4 mL/min. The
HPLC run contained blanks and the sample-relevant standard
solution. Samples and standards were ﬁltered using a 0.2 μM
ﬁlter.
Conjugation/Transformation Eﬃciency Determina-
tion and Mutant Screening. For conjugation eﬃciency
assays, the donor strain, E. coli CA434 (in triplicates), was
grown overnight at 30 °C in LB supplemented with kanamycin
and chloramphenicol. For each replica, two 1 mL cultures were
centrifuged at 6000g for 1 min and then washed once with
phosphate-buﬀered saline (PBS). After a second centrifugation
step, one of the two cultures was used to quantify the donor by
plating the appropriate serial dilutions onto LB plates. The
second culture was transferred to the anaerobic cabinet and
mixed with 200 μL of a 12-h C. sporogenes culture. The mixture
was spotted onto the TYG medium supplemented with
glucose. After 8 h, cells were harvested, resuspended in 500
μL of PBS and plated onto media supplemented with
thiamphenicol and D-cycloserine, in the presence and absence
of the inducer theophylline. After 24−48 h of incubation at 37
°C, colonies were counted and conjugation eﬃciency was
calculated as total transconjugants per 1 mL of donor strain.
Transformation eﬃciency in C. pasteurianum was deter-
mined as the average of three independent transformations
with 4 μg of plasmid DNA.
Single colonies were picked randomly and screened for
desired mutants using colony PCR and speciﬁc ﬂanking
primers. In all cases, mutations were further conﬁrmed with
Sanger sequencing (data not shown).
DNA Sequencing and Bioinformatics. Genomic DNA
was isolated from C. sporogenes overnight cultures using
phenol-chloroform extraction. Genome sequencing was
provided by MicrobesNG, using their Illumina-based, Standard
Whole-Genome Service (http://www.microbesng.uk). Whole
genome sequencing data were assembled and analyzed using
the CLC Genomics Workbench version 10 (Qiagen).
Resequencing analysis for the identiﬁcation of single
nucleotide variants (SNVs) was carried out using the Basic
Variant Detection tool and the program’s default parameters.
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and Lopes Ferreira, N. (2017) A two-plasmid inducible CRISPR/
Cas9 genome editing tool for Clostridium acetobutylicum. J. Microbiol.
Methods 140, 5−11.
(16) Wang, Y., et al. (2015) Markerless chromosomal gene deletion
in Clostridium beijerinckii using CRISPR/Cas9 system. J. Biotechnol.
200, 1−5.
(17) Wang, S. (2018) Genome engineering of Clostridium dif f icile
using the CRISPR-Cas9 system. Clin. Microbiol. Infect. 24, 1095.
(18) McAllister, K. N., Bouillaut, L., Kahn, J. N., Self, W. T., and
Sorg, J. A. (2017) Using CRISPR-Cas9-mediated genome editing to
generate C. dif f icile mutants defective in selenoproteins synthesis. Sci.
Rep. 7, 14672.
(19) Shen, B., et al. (2014) Efficient genome modification by
CRISPR-Cas9 nickase with minimal off-target effects. Nat. Methods
11, 399−402.
(20) Xu, T., et al. (2015) Efficient genome editing in Clostridium
cellulolyticum via CRISPR-Cas9 nickase. Appl. Environ. Microbiol. 81,
4423−4431.
(21) Li, Q., et al. (2016) CRISPR-based genome editing and
expression control systems in Clostridium acetobutylicum and
Clostridium beijerinckii. Biotechnol. J. 11, 961−972.
(22) Groher, F., and Suess, B. (2014) Synthetic riboswitches - A tool
comes of age. Biochim. Biophys. Acta, Gene Regul. Mech. 1839, 964−
973.
(23) Lynch, S. A., Desai, S. K., Sajja, H. K., and Gallivan, J. P. (2007)
A high-throughput screen for synthetic riboswitches reveals
mechanistic insights into their function. Chem. Biol. 14, 173−84.
(24) Cui, W., et al. (2016) Engineering an inducible gene expression
system for Bacillus subtilis from a strong constitutive promoter and a
theophylline-activated synthetic riboswitch. Microb. Cell Fact.,
DOI: 10.1186/s12934-016-0599-z.
(25) Rudolph, M. M., Vockenhuber, M. P., and Suess, B. (2015)
Conditional control of gene expression by synthetic riboswitches in
Streptomyces coelicolor. Methods Enzymol. 550, 283−299.
(26) Nakahira, Y., Ogawa, A., Asano, H., Oyama, T., and Tozawa, Y.
(2013) Theophylline-dependent riboswitch as a novel genetic tool for
strict regulation of protein expression in cyanobacterium Synecho-
coccus elongatus PCC 7942. Plant Cell Physiol. 54, 1724−35.
(27) Dwidar, M., and Yokobayashi, Y. (2017) Controlling
Bdellovibrio bacteriovorus gene expression and predation using
synthetic riboswitches. ACS Synth. Biol. 6, 2035.
ACS Synthetic Biology Research Article
DOI: 10.1021/acssynbio.9b00075
ACS Synth. Biol. 2019, 8, 1379−1390
1389
(28) Topp, S., et al. (2010) Synthetic riboswitches that induce gene
expression in diverse bacterial species. Appl. Environ. Microbiol. 76,
7881−4.
(29) Ohbayashi, R., Akai, H., Yoshikawa, H., Hess, W. R., and
Watanabe, S. (2016) A tightly inducible riboswitch system in
Synechocystis sp. PCC 6803. J. Gen. Appl. Microbiol. 62, 154−159.
(30) Heap, J. T., Pennington, O. J., Cartman, S. T., and Minton, N.
P. (2009) A modular system for Clostridium shuttle plasmids. J.
Microbiol. Methods 78, 79−85.
(31) Davis, J. H., Rubin, A. J., and Sauer, R. T. (2011) Design,
construction and characterization of a set of insulated bacterial
promoters. Nucleic Acids Res. 39, 1131−41.
(32) Bhattacharyya, S., et al. (2018) Accessibility of the Shine-
Dalgarno Sequence Dictates N-Terminal Codon Bias in E. coli. Mol.
Cell 70, 894−905.
(33) Mustoe, A. M., et al. (2018) Pervasive regulatory functions of
mRNA structure revealed by high-resolution SHAPE probing. Cell
173, 181−195.
(34) Desai, S. K., and Gallivan, J. P. (2004) Genetic screens and
selections for small molecules based on a synthetic riboswitch that
activates protein translation. J. Am. Chem. Soc. 126, 13247−54.
(35) Huang, H., et al. (2016) CRISPR/Cas9-based efficient genome
editing in Clostridium ljungdahlii, an autotrophic gas-fermenting
bacterium. ACS Synth. Biol. 5, 1355−1361.
(36) Peters, J. M., et al. (2015) Bacterial CRISPR: accomplishments
and prospects. Curr. Opin. Microbiol. 27, 121−6.
(37) Selle, K., and Barrangou, R. (2015) Harnessing CRISPR-Cas
systems for bacterial genome editing. Trends Microbiol. 23, 225−232.
(38) Guo, C.-J. et al. (2018) Depletion of microbiome-derived
molecules in the host using Clostridium genetics. bioRxiv
DOI: 10.1101/401489.
(39) Hong, W., Zhang, J., Cui, G., Wang, L., and Wang, Y. (2018)
Multiplexed CRISPR-Cpf1-mediated genome editing in Clostridium
dif f icile: toward the understanding of pathogenesis of C. dif f icile
Infection. ACS Synth. Biol. 7, 1588−1600.
(40) Mougiakos, I., Bosma, E. F., Ganguly, J., van der Oost, J., and
van Kranenburg, R. (2018) Hijacking CRISPR-Cas for high-
throughput bacterial metabolic engineering: advances and prospects.
Curr. Opin. Biotechnol. 50, 146−157.
(41) Sambrook, J., and Russell, D. W. (2001) Molecular Cloning: A
Laboratory Manual, Cold Spring Harbor Laboratory Press.
(42) Shaw, W. V. (1975) Chloramphenicol acetyltransferase from
chloramphenicol-resistant bacteria. Methods Enzymol. 43, 737−55.
(43) Silverstein, R. M. (1975) The determination of the molar
extinction coefficient of reduced DTNB. Anal. Biochem. 63, 281−2.
ACS Synthetic Biology Research Article
DOI: 10.1021/acssynbio.9b00075
ACS Synth. Biol. 2019, 8, 1379−1390
1390
